We developed a prognostic classification method for patients with ccRCC based on SLC25A23, SLC25A42, SLC5A1, SLC3A1, SLC25A37, SLC5A6, SLCO5A1, and SCP2. This evidence concerns the gene SCP2 and nonpapillary renal cell carcinoma.